PHM7D Stock Overview
Through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 2/6 |
Dividends | 6/6 |
Altria Group, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$53.19 |
52 Week High | US$53.38 |
52 Week Low | US$36.17 |
Beta | 0.67 |
11 Month Change | 15.08% |
3 Month Change | 14.20% |
1 Year Change | 42.56% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 22.93% |
Recent News & Updates
Recent updates
Shareholder Returns
PHM7D | GB Tobacco | GB Market | |
---|---|---|---|
7D | 2.2% | 4.1% | 2.2% |
1Y | 42.6% | 19.8% | 8.0% |
Return vs Industry: PHM7D exceeded the UK Tobacco industry which returned 19.8% over the past year.
Return vs Market: PHM7D exceeded the UK Market which returned 8% over the past year.
Price Volatility
PHM7D volatility | |
---|---|
PHM7D Average Weekly Movement | n/a |
Tobacco Industry Average Movement | 2.4% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 10.3% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: PHM7D's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine PHM7D's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1822 | 6,400 | Billy Gifford | www.altria.com |
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand.
Altria Group, Inc. Fundamentals Summary
PHM7D fundamental statistics | |
---|---|
Market cap | €92.33b |
Earnings (TTM) | €9.85b |
Revenue (TTM) | €19.55b |
9.4x
P/E Ratio4.7x
P/S RatioIs PHM7D overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PHM7D income statement (TTM) | |
---|---|
Revenue | US$20.36b |
Cost of Revenue | US$6.16b |
Gross Profit | US$14.20b |
Other Expenses | US$3.94b |
Earnings | US$10.26b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 6.05 |
Gross Margin | 69.76% |
Net Profit Margin | 50.39% |
Debt/Equity Ratio | -736.0% |
How did PHM7D perform over the long term?
See historical performance and comparison